Muralimohan T. Reddy

Statistics

Publications

Citations

451

H-Index

Active since

2000

Affiliations

Sarepta Therapeutics (United States)(Current)

Muralimohan T. Reddy is an author at Sarepta Therapeutics (United States) specializing in morpholino oligomers, morpholino oligonucleotides, and pharmacology.

Publications per year

2000–2007

Publications

Pharmacokinetics, Biodistribution, Stability and Toxicity of a Cell-Penetrating Peptide−Morpholino Oligomer Conjugate

Adams Amantana, Hong M. Moulton, Melissa L. Cate et al. · Bioconjugate Chemistry · 2007 · 206 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Bioavailability and Efficacy of Antisense Morpholino Oligomers Targeted to c-myc and Cytochrome P-450 3A2 Following Oral Administration in Rats

Vikram Arora, Derek C. Knapp, Muralimohan T. Reddy et al. · Journal of Pharmaceutical Sciences · 2002 · 78 citations

Medicine, Pharmacokinetics, Pharmacology +13

c-Myc Antisense Limits Rat Liver Regeneration and Indicates Role for c-Myc in Regulating Cytochrome P-450 3A Activity

Vikram Arora, Derek C. Knapp, Barbara L. Smith et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 71 citations

Life Sciences, Cell Biology, Molecular Biology +13

Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model

Derek C. Knapp, John E. Mata, Muralimohan T. Reddy et al. · Anti-Cancer Drugs · 2003 · 67 citations

Medicine, Oncology, Pharmacology +16

ANDROGEN RECEPTOR DOWN-REGULATION IN PROSTATE CANCER WITH PHOSPHORODIAMIDATE MORPHOLINO ANTISENSE OLIGOMERS

Yoo‐Joung Ko, Gayathri R. Devi, Carla A. London et al. · The Journal of Urology · 2004 · 29 citations

Medicine, Oncology, Pharmacology +17

1–5 of 5